EP 1315705 A1 20030604 - BICYCLIC HETEROCYCLES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE, AND METHODS FOR THE PRODUCTION THEREOF
Title (en)
BICYCLIC HETEROCYCLES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE, AND METHODS FOR THE PRODUCTION THEREOF
Title (de)
BICYCLISCHE HETEROCYCLEN, DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL, DEREN VERWENDUNG UND VEFAHREN ZU IHRER HERSTELLUNG
Title (fr)
HETEROCYCLES BICYCLIQUES, MEDICAMENTS CONTENANT LESDITS COMPOSES, LEUR UTILISATION ET PROCEDES PERMETTANT DE LES PRODUIRE
Publication
Application
Priority
- DE 10042058 A 20000826
- EP 0109532 W 20010818
Abstract (en)
[origin: WO0218351A1] The invention relates to bicyclic heterocycles of general formula (I), in which Ra to Rc are defined as referred to in Claims Nos. 1 to 7, to their tautomers, their stereoisomers, and to their salts, particularly their physiologically compatible salts with inorganic or organic acids or bases, which have valuable pharmacological properties, in particular, an inhibitive effect on the signal transduction imparted by tyrosine kinases. The invention also relates to the use of said bicyclic heterocycles for treating diseases, especially tumor diseases, disorders of the lung and of the respiratory tract, and to the production thereof.
IPC 1-7
C07D 239/94; C07D 405/12; C07D 413/12; C07D 413/14; A61K 31/517; A61P 35/00
IPC 8 full level
A61K 31/517 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 11/08 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 27/16 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 239/94 (2006.01); C07D 405/12 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01)
CPC (source: EP KR)
A61P 1/00 (2018.01 - EP); A61P 1/04 (2018.01 - EP); A61P 1/16 (2018.01 - EP); A61P 11/00 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 11/08 (2018.01 - EP); A61P 13/12 (2018.01 - EP); A61P 17/00 (2018.01 - EP); A61P 27/16 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 35/04 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 239/94 (2013.01 - EP); C07D 405/12 (2013.01 - EP); C07D 413/12 (2013.01 - EP KR); C07D 413/14 (2013.01 - EP)
Citation (examination)
WO 0055141 A1 20000921 - BOEHRINGER INGELHEIM PHARMA [DE], et al
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0218351 A1 20020307; AR 033562 A1 20031226; AU 2001287694 B2 20070906; AU 8769401 A 20020313; BG 107559 A 20031031; BR 0113519 A 20030701; CA 2417897 A1 20030130; CA 2417897 C 20090331; CN 100404517 C 20080723; CN 1449390 A 20031015; CZ 302567 B6 20110713; DE 10042058 A1 20020307; EA 005679 B1 20050428; EA 200300219 A1 20030828; EC SP034464 A 20030331; EE 05269 B1 20100215; EE 200300077 A 20041215; EP 1315705 A1 20030604; HK 1057557 A1 20040408; HR P20030138 A2 20050430; HU P0300819 A2 20030929; HU P0300819 A3 20080328; IL 154602 A0 20030917; IL 154602 A 20080708; JP 2004507529 A 20040311; JP 4834282 B2 20111214; KR 100862873 B1 20081015; KR 20030024914 A 20030326; ME P58708 A 20110510; MX PA03001483 A 20030606; MY 126132 A 20060929; NO 20030870 D0 20030225; NO 20030870 L 20030225; NO 324866 B1 20071217; NZ 524668 A 20060630; PL 360248 A1 20040906; RS 52279 B 20121031; SK 2312003 A3 20031007; SK 287747 B6 20110804; TW I294422 B 20080311; UA 73004 C2 20050516; UY 26903 A1 20020322; YU 14003 A 20060116; ZA 200300991 B 20040416
DOCDB simple family (application)
EP 0109532 W 20010818; AR P010104041 A 20010824; AU 2001287694 A 20010818; AU 8769401 A 20010818; BG 10755903 A 20030214; BR 0113519 A 20010818; CA 2417897 A 20010818; CN 01814635 A 20010818; CZ 2003870 A 20010818; DE 10042058 A 20000826; EA 200300219 A 20010818; EC SP034464 A 20030203; EE P200300077 A 20010818; EP 01967285 A 20010818; HK 04100462 A 20040121; HR P20030138 A 20030224; HU P0300819 A 20010818; IL 15460201 A 20010818; IL 15460203 A 20030224; JP 2002523469 A 20010818; KR 20037002744 A 20030225; ME P58708 A 20010818; MX PA03001483 A 20010818; MY PI20013985 A 20010824; NO 20030870 A 20030225; NZ 52466801 A 20010818; PL 36024801 A 20010818; SK 2312003 A 20010818; TW 90120905 A 20010824; UA 200332533 A 20010818; UY 26903 A 20010823; YU P14003 A 20010818; ZA 200300991 A 20030205